Clinical trial
Tricaprilin In Age-Associated Memory Impairment
NCT00355550 · Cerecin, Industry · Completed
Key facts
| NCT number | NCT00355550 |
|---|---|
| Title | Tricaprilin In Age-Associated Memory Impairment |
| Official title | A Double-Blind, Placebo-Controlled Study of Tricaprilin (AC-1202) Administered For Ninety Days In Subjects With Age-Associated Memory Impairment |
| Lead sponsor | Cerecin, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Age-Associated Memory Impairment |
| Intervention type | Drug, Other |
| Interventions | Tricaprilin, Placebo |
| Enrollment | 156 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jul 24, 2006 |
| Last update posted | Sep 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: